Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cristina Auger

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 10, 2025
Performance of treatment response scoring systems among patients with multiple sclerosis treated with high-efficacy therapiesMariano Marrodan, Augusto Sao Avilés, Jordi Río, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 7, 2023
Global and Regional Deep Learning Models for Multiple Sclerosis Stratification From MRILlucia Coll, Deborah Pareto, Pere Carbonell-Mirabent, et al.
Neurology|August 14, 2016
Neurofilament light chain level is a weak risk factor for the development of MSGeorgina Arrambide, Carmen Espejo, Herena Eixarch, et al.
Annals of Neurology|September 14, 2023
Myelin Oligodendrocyte Glycoprotein Antibodies in Adults with a First Demyelinating Event Suggestive of Multiple SclerosisJavier Villacieros-Álvarez, Carmen Espejo, Georgina Arrambide, et al.
The Lancet Regional Health. Europe|April 28, 2025
The Barcelona baseline risk score to predict long-term prognosis after a first demyelinating event: a prospective observational studyCarmen Tur, Pere Carbonell-Mirabent, Susana Otero-Romero, et al.
Neurology|January 2, 2024
Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria: A Longitudinal, Prospective, Multicenter StudyAngela Vidal-Jordana, Alex Rovira, Willem Calderon, et al.
Neurology|July 19, 2023
Association of Very Early Treatment Initiation With the Risk of Long-term Disability in Patients With a First Demyelinating EventAlvaro Cobo-Calvo, Carmen Tur, Susana Otero-Romero, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 30, 2025
Radiologically isolated syndrome: How could we accurately diagnose a subclinical period of multiple sclerosis?Andreu Vilaseca, Angela Vidal-Jordana, Sofia Sceppacuercia, et al.
The Lancet. Neurology|February 15, 2020
Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational studyThaís Armangue, Gemma Olivé-Cirera, Eugenia Martínez-Hernandez, et al.
Brain Communications|July 7, 2025
Deep learning to predict progression independent of relapse activity at a first demyelinating eventLlucia Coll, Deborah Pareto, Francisco Aparicio-Serrano, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 10, 2025
Performance of treatment response scoring systems among patients with multiple sclerosis treated with high-efficacy therapiesMariano Marrodan, Augusto Sao Avilés, Jordi Río, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 7, 2023
Global and Regional Deep Learning Models for Multiple Sclerosis Stratification From MRILlucia Coll, Deborah Pareto, Pere Carbonell-Mirabent, et al.
Neurology|August 14, 2016
Neurofilament light chain level is a weak risk factor for the development of MSGeorgina Arrambide, Carmen Espejo, Herena Eixarch, et al.
Annals of Neurology|September 14, 2023
Myelin Oligodendrocyte Glycoprotein Antibodies in Adults with a First Demyelinating Event Suggestive of Multiple SclerosisJavier Villacieros-Álvarez, Carmen Espejo, Georgina Arrambide, et al.
The Lancet Regional Health. Europe|April 28, 2025
The Barcelona baseline risk score to predict long-term prognosis after a first demyelinating event: a prospective observational studyCarmen Tur, Pere Carbonell-Mirabent, Susana Otero-Romero, et al.
Neurology|January 2, 2024
Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria: A Longitudinal, Prospective, Multicenter StudyAngela Vidal-Jordana, Alex Rovira, Willem Calderon, et al.
Neurology|July 19, 2023
Association of Very Early Treatment Initiation With the Risk of Long-term Disability in Patients With a First Demyelinating EventAlvaro Cobo-Calvo, Carmen Tur, Susana Otero-Romero, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 30, 2025
Radiologically isolated syndrome: How could we accurately diagnose a subclinical period of multiple sclerosis?Andreu Vilaseca, Angela Vidal-Jordana, Sofia Sceppacuercia, et al.
The Lancet. Neurology|February 15, 2020
Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational studyThaís Armangue, Gemma Olivé-Cirera, Eugenia Martínez-Hernandez, et al.
Brain Communications|July 7, 2025
Deep learning to predict progression independent of relapse activity at a first demyelinating eventLlucia Coll, Deborah Pareto, Francisco Aparicio-Serrano, et al.
Pageof 10